rxstat › Shortages › Caspofungin

Caspofungin shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Caspofungin has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 6
Reports on file
16

Reports by product

To be discontinued
CANCIDAS
70MG · POWDER FOR SOLUTION · MERCK CANADA INC
DIN 02244266
Discontinued
CANCIDAS
50MG · POWDER FOR SOLUTION · MERCK CANADA INC
DIN 02244265
Resolved
CASPOFUNGIN FOR INJECTION
50MG · POWDER FOR SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02486989 · ended Sep 26, 2024 · Disruption of the manufacture of the drug.
Resolved
CASPOFUNGIN FOR INJECTION
50MG · POWDER FOR SOLUTION · JUNO PHARMACEUTICALS CORP.
DIN 02460947 · ended Aug 6, 2024 · Other (Please describe in comments)
Resolved
CASPOFUNGIN FOR INJECTION
70MG · POWDER FOR SOLUTION · JUNO PHARMACEUTICALS CORP.
DIN 02460955 · ended Aug 6, 2024 · Other (Please describe in comments)
Resolved
CASPOFUNGIN FOR INJECTION
50MG · POWDER FOR SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02486989 · ended Feb 29, 2024 · Disruption of the manufacture of the drug.
Resolved
CASPOFUNGIN FOR INJECTION
50MG · POWDER FOR SOLUTION · JUNO PHARMACEUTICALS CORP.
DIN 02460947 · ended Jan 17, 2024 · Demand increase for the drug.
Resolved
CASPOFUNGIN FOR INJECTION
70MG · POWDER FOR SOLUTION · JUNO PHARMACEUTICALS CORP.
DIN 02460955 · ended Jan 17, 2024 · Demand increase for the drug.
Resolved
CANCIDAS
50MG · POWDER FOR SOLUTION · MERCK CANADA INC
DIN 02244265 · ended Dec 14, 2023 · Delay in shipping of the drug.
Resolved
CANCIDAS
70MG · POWDER FOR SOLUTION · MERCK CANADA INC
DIN 02244266 · ended Nov 29, 2023 · Demand increase for the drug.
Resolved
CANCIDAS
50MG · POWDER FOR SOLUTION · MERCK CANADA INC
DIN 02244265 · ended Oct 31, 2023 · Demand increase for the drug.
Resolved
CASPOFUNGIN FOR INJECTION
70MG · POWDER FOR SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02486997 · ended Jan 23, 2023 · Disruption of the manufacture of the drug.

Showing 12 of 16 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Caspofungin. Health Canada has 16 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Caspofungin is classified under “ANTIMYCOTICS FOR SYSTEMIC USE” (ATC J02AX).

Recent changes

Common questions

When will Caspofungin be back in stock in Canada?

Caspofungin has no active shortage; supply is normal per Health Canada reports.

Why is Caspofungin in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antimycotics for systemic use)

Widespread shortageMicafungin2 of 3 reported products affectedPartial shortageFluconazole1 of 18 reported products affected · est. return Jun 5, 2026Partial shortageKetoconazole1 of 3 reported products affectedPartial shortageVoriconazole2 of 12 reported products affected · est. return Oct 9, 2026No current shortageAmphotericin BNo current shortageItraconazole

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.